Sequent-Viyash may soon have zero debt: Viyash founder and combined co's CEO-designate Hari Babu Bodepudi to inject ₹400 crore

Hari Babu Bodepudi is making a significant capital infusion into the newly merged Sequent Scientific and Viyash Life Sciences. This strategic investment will effectively reduce the combined company's net debt to nearly zero. Under Carlyle's leadership, the newly formed entity is poised to surpass a market capitalization of $1 billion.